Ben Trotman had an invasive growth of cells called a glioblastoma, which leaves patients with an average nine-month life expectancy
The only person in the world to receive a groundbreaking treatment for brain cancer is doing well almost a year and a half later, a charity has said.
Ben Trotman, 41, took part in a clinical trial that used immunotherapy to target his glioblastoma, an invasive growth of cells in the brain that gives an average life expectancy of nine months.
